| Ticker Details |
|
Twist Bioscience Corporation
|
| IPO Date: |
October 29, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$3.77B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.69 | 3.37%
|
| Avg Daily Range (30 D): |
$1.80 | 3.26%
|
| Avg Daily Range (90 D): |
$1.55 | 3.14%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.74M |
| Avg Daily Volume (30 D): |
1.21M |
| Avg Daily Volume (90 D): |
1.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
55 |
| Avg Trade Size (Sh.) (30 D): |
53 |
| Avg Trade Size (Sh.) (90 D): |
53 |
| Institutional Trades |
| Total Institutional Trades: |
3,753 |
| Avg Institutional Trade: |
$3.37M |
| Avg Institutional Trade (30 D): |
$3.58M |
| Avg Institutional Trade (90 D): |
$3.4M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.48M |
| Avg Closing Trade (30 D): |
$10.82M |
| Avg Closing Trade (90 D): |
$8.74M |
| Avg Closing Volume: |
128.66K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-1.32
|
$-.71
|
$-.5
|
|
Diluted EPS
|
$-1.33
|
$-.71
|
$-.5
|
|
Revenue
|
$409.48M
|
$110.72M
|
$103.7M
|
|
Gross Profit
|
$213.23M
|
$57.12M
|
$53.97M
|
|
Net Income / Loss
|
$-81.28M
|
$-44.02M
|
$-30.51M
|
|
Operating Income / Loss
|
$-138.82M
|
$-45.86M
|
$-32.9M
|
|
Cost of Revenue
|
$196.25M
|
$53.59M
|
$49.73M
|
|
Net Cash Flow
|
$-88.1M
|
$-26.13M
|
$-34.44M
|
|
PE Ratio
|
|
|
|
|
|
|